Fifty-three year follow-up of coronary heart disease versus HDL2 and other lipoproteins in Gofman's livermore cohort

Journal of Lipid Research

Volumn 53, Issue 2, 2012, Pages 266-272

  Williams, Paul T ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

High density lipoproteins; Prevention; Risk factors

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CAUSE OF DEATH; COHORT ANALYSIS; DEATH CERTIFICATE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; ULTRACENTRIFUGATION;

ADULT; AGED; BLOOD PRESSURE; CHOLESTEROL; COHORT STUDIES; CORONARY DISEASE; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEINS, HDL2; LIPOPROTEINS, HDL3; LIPOPROTEINS, IDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84855653646     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M019356     Document Type: Article

References (29)

1. Lindgren, F. T., H. A. Elliott, and J. W. Gofman. 1951. The ultra-centrifugal characterization and isolation of human blood lipids and lipoproteins, with applications to the study of atherosclerosis. J. Phys. Colloid Chem. 55: 80-93.
2. De Lalla, O. F., and J. W. Gofman. 1954. Ultracentrifugal analysis of serum lipoproteins. Methods Biochem. Anal. 1: 459-478.
3. Gofman, J. W., W. Young, and R. Tandy. 1966. Ischemic heart disease, atherosclerosis, and longevity. Circulation. 34: 679-697.
4. Fujimoto, W. Y., R. W. Bergstrom, E. J. Boyko, K. W. Chen, D. L. Leonetti, L. Newell-Morris, J. B. Shofer, and P. W. Wahl. 1999. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care. 22: 1808-1812. (Pubitemid 29521866)
5. Laakso, M., S. Lehto, I. Penttilä, and K. Pyörälä. 1993. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation. 88: 1421-1430. (Pubitemid 23296887)
6. Lamarche, B., S. Moorjani, B. Cantin, G. R. Dagenais, P. J. Lupien, and J. P. Després. 1997. Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Arterioscler. Thromb. Vasc. Biol. 17: 1098-1105. (Pubitemid 27260329)
7. Salonen, J. T., R. Salonen, K. Seppänen, R. Rauramaa, and J. Tuomilehto. 1991. HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation. 84: 129-139.
8. Sharrett, A. R., C. M. Ballantyne, S. A. Coady, G. Heiss, P. D. Sorlie, D. Catellier, and W. Patsch. 2001. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 104: 1108-1113. (Pubitemid 32830392)
9. Stampfer, M. J., F. M. Sacks, S. Salvini, W. C. Willett, and C. H. Hennekens. 1991. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N. Engl. J. Med. 325: 373-381.
10. Mora, S., J. D. Otvos, N. Rifai, R. S. Rosenson, J. E. Buring, and P. M. Ridker. 2009. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation. 119: 931-939.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285: 2486-2497.
12. Williams, P. T., R. M. Krauss, K. M. Vranizan, M. L. Stefanick, P. D. Wood, and F. T. Lindgren. 1992. Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women. Arterioscler. Thromb. 12: 332-340.
13. Franceschini, G., C. Tosi, Y. Moreno, and C. R. Sirtori. 1985. Effects of storage on the distribution of high density lipoprotein subfractions in human sera. J. Lipid Res. 26: 1368-1373. (Pubitemid 16208315)
14. Daerr, W. H., E. E. Windler, H. D. Rohwer, and H. Greten. 1983. Limitations of a new double-precipitation method for the determination of high density lipoprotein subfractions 2 and 3. Atherosclerosis. 49: 211-213.
15. Johansson, J., P. Nilsson-Ehle, L. A. Carlson, and A. Hamsten. 1991. The association of lipoprotein and hepatic lipase activities with high density lipoprotein subclass levels in men with myocardial infarction at a young age. Atherosclerosis. 86: 111-122.
16. Otvos, J. D., E. J. Jeyarajah, D. W. Bennett, and R. M. Krauss. 1992. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin. Chem. 38: 1632-1638.
17. Williams, P. T., and D. E. Feldman. 2011. Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort. Atherosclerosis. 214: 196-202.
18. Gofman, J. W., M. Hanig, H. B. Jones, M. A. Lauffer, E. Y. Lawry, L. A. Lewis, G. V. Mann, F. E. Moore, F. Olmsted, J. F. Yeager, et al. 1956. Evaluation of serum lipoprotein and cholesterol measurements as predictors of clinical complications of atherosclerosis; report of a cooperative study of lipoproteins and atherosclerosis. Circulation. 14: 689-741.
19. Colman, D. M., and A. F. McPhee. 1956. An improved method for determination of total serum cholesterol. Am. J. Clin. Pathol. 26: 181-186.
20. National Center for Health Statistics. 1990. National Death Index User's Manual. US Department of Health and Human Services and Centers for Disease Control, Hyattsville, MD.
21. Wood, P. D., M. L. Stefanick, P. T. Williams, and W. L. Haskell. 1991. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N. Engl. J. Med. 325: 461-466.
22. Wood, P. D., M. L. Stefanick, D. M. Dreon, B. Frey-Hewitt, S. C. Garay, P. T. Williams, H. R. Superko, S. P. Fortmann, J. J. Albers, K. M. Vranizan, et al. 1988. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N. Engl. J. Med. 319: 1173-1179.
23. Warnick, R., J. Benderson, and J. Albers. 1982. Quantitation of high density lipoprotein subclasses after separation by dextran sulfate and Mg2+ precipitation. Clin. Chem. 28: 1379-1388.
24. Assmann, G., H. Schulte, A. von Eckardstein, and Y. Huang. 1996. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. 124 (Suppl.) : S11-S20.
25. Gordon, D. J., J. L. Probstfield, R. J. Garrison, J. D. Neaton, W. P. Castelli, J. D. Knoke, D. R. Jacobs, Jr., S. Bangdiwala, and H. A. Tyroler. 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79: 8-15. (Pubitemid 19043669)
26. Nordestgaard, B. G., M. Benn, P. Schnohr, and A. Tybjaerg-Hansen. 2007. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 298: 299-308. (Pubitemid 47080484)
27. Bansal, S., J. E. Buring, N. Rifai, S. Mora, F. M. Sacks, and P. M. Ridker. 2007. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 298: 309-316. (Pubitemid 47080485)
28. Barter, P. J., M. Caulfield, M. Eriksson, S. M. Grundy, J. J. Kastelein, M. Komajda, J. Lopez-Sendon, L. Mosca, J. C. Tardiff, D. D. Waters, et al. 2007. Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 357: 2109-2122. (Pubitemid 350146106)
29. Catalano, G., Z. Julia, E. Frisdal, B. Vedie, N. Fournier, W. Le Goff, M. J. M. Chapman, and M. Guerin. 2009. Torcetrapib differentially modulates the biological activities of HDL2 and HDL3 particles in the reverse cholesterol transport pathway. Arterioscler. Thromb. Vasc. Biol. 29: 268-275.